+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07064018

Phase 1bIIa Study of SPEDOX-6, a Single Protein Encapsulated Doxorubicin, for Advanced Treatment-Resistant Cancers Including Soft-Tissue Sarcoma, Triple-Negative Breast Cancer, Lung, Cervical, Ovarian, and KRAS Mutant Pancreatic Cancer

Led by University of California, Irvine · Updated on 2026-07-17

67

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase 1bIIa clinical trial to find the recommended Phase II dose of SPEDOX-6 in adults with advanced, treatment-resistant cancers including soft-tissue sarcoma, triple-negative breast cancer, non-small cell lung cancer, cervical cancer, ovarian cancer, and KRAS mutant pancreatic ductal adenocarcinoma. Participants must not have been previously treated with anthracyclines. The trial aims to evaluate the safety and effectiveness of this treatment in these difficult-to-treat cancers. Participants receive SPEDOX-6 chemotherapy intravenously on the first day of each 21-day cycle, for up to six cycles. The dose of SPEDOX-6 escalates through several levels, ranging from 20 mgm2 to 310 mgm2. Some dose levels also include supportive drugs called Filgrastim or Pegfilgrastim, given by injection or IV to help manage side effects, following institutional standards. Throughout the study, participants undergo various assessments including tumor measurements using RECIST v1.1 criteria to track response rates, disease control, and survival over two years. Safety is closely monitored for side effects like blood cell changes and liver enzyme elevations using standardized criteria. The trial involves regular visits during treatment cycles with detailed follow-up for up to two years to evaluate outcomes and health status.

CONDITIONS

Brief Title

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Research Team

C

Chao Family Comprehensive Cancer Center University of California, Irvine

U

University of California Irvine Medical Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here